PL3538132T3 - Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit - Google Patents

Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit

Info

Publication number
PL3538132T3
PL3538132T3 PL17804828T PL17804828T PL3538132T3 PL 3538132 T3 PL3538132 T3 PL 3538132T3 PL 17804828 T PL17804828 T PL 17804828T PL 17804828 T PL17804828 T PL 17804828T PL 3538132 T3 PL3538132 T3 PL 3538132T3
Authority
PL
Poland
Prior art keywords
treatment
inflammatory bowel
bowel diseases
rectal insulin
rectal
Prior art date
Application number
PL17804828T
Other languages
English (en)
Inventor
Jørgen OLSEN
Mohammad Taha Yassin
Elm Anders Pedersen
Original Assignee
University Of Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Copenhagen filed Critical University Of Copenhagen
Publication of PL3538132T3 publication Critical patent/PL3538132T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17804828T 2016-11-14 2017-11-10 Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit PL3538132T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16198633 2016-11-14
PCT/EP2017/078900 WO2018087298A1 (en) 2016-11-14 2017-11-10 Rectal insulin for treatment of inflammatory bowel diseases
EP17804828.6A EP3538132B1 (en) 2016-11-14 2017-11-10 Rectal insulin for treatment of inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
PL3538132T3 true PL3538132T3 (pl) 2021-06-28

Family

ID=57321168

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17804828T PL3538132T3 (pl) 2016-11-14 2017-11-10 Insulina doodbytnicza do leczenia nieswoistego zapalenia jelit

Country Status (9)

Country Link
US (1) US11400137B2 (pl)
EP (1) EP3538132B1 (pl)
CA (1) CA3041390A1 (pl)
DK (1) DK3538132T3 (pl)
EA (1) EA201991166A1 (pl)
ES (1) ES2850650T3 (pl)
PL (1) PL3538132T3 (pl)
PT (1) PT3538132T (pl)
WO (1) WO2018087298A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201910224VA (en) 2017-06-29 2020-01-30 Ascendis Pharma As Auto injector with reconstitution handling support
JP7017198B2 (ja) * 2018-06-22 2022-02-08 株式会社Ａｉメディカルサービス 消化器官の内視鏡画像による疾患の診断支援方法、診断支援システム、診断支援プログラム及びこの診断支援プログラムを記憶したコンピュータ読み取り可能な記録媒体
US20220175885A1 (en) 2019-03-20 2022-06-09 Reponex Pharmaceuticals A/S Targeting biological agents to mucosal defects of the gastrointestinal tract
CN122028907A (zh) * 2023-10-13 2026-05-12 恩特罗泰格特有限公司 用于将含有局部作用有效载荷的载体系统递送到哺乳动物肠道的胶囊

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2051574B (en) 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4406896A (en) 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
JP2921872B2 (ja) * 1989-08-28 1999-07-19 和光純薬工業株式会社 経粘膜製剤
CA2209016A1 (en) 1994-12-28 1996-07-04 Teikoku Hormone Mfg. Co., Ltd. Pharmaceutics for mucosal administration
WO1997034580A1 (en) 1996-03-21 1997-09-25 Dong Wha Pharmaceutical Industrial Co., Ltd. Suppository composition of the drug which has gastro-intestinal disturbances or undergoes the decomposition by gastric acid
CN1630532A (zh) * 2000-04-19 2005-06-22 约翰斯霍普金斯大学 预防和治疗胃肠疾病的方法
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
EP1390015A1 (en) 2001-05-31 2004-02-25 Cima Labs Inc. Taste-masking of highly water-soluble drugs
US20070219131A1 (en) 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US8026211B2 (en) 2004-06-02 2011-09-27 Technion Research & Development Foundation Ltd. Methods and formulations for increasing intestinal function
WO2008132732A2 (en) 2007-04-26 2008-11-06 Oramed Pharmaceuticals Inc Methods and compositions for rectal administration of proteins
WO2008132731A2 (en) 2007-04-26 2008-11-06 Oramed Pharmaceuticals, Inc Methods and compositions for rectal administration of insulin
RU2678833C2 (ru) 2008-09-17 2019-02-04 Киазма Инк. Фармацевтические композиции и соответствующие способы доставки

Also Published As

Publication number Publication date
US20210038696A1 (en) 2021-02-11
ES2850650T3 (es) 2021-08-31
EA201991166A1 (ru) 2019-09-30
US11400137B2 (en) 2022-08-02
PT3538132T (pt) 2021-02-05
WO2018087298A1 (en) 2018-05-17
CA3041390A1 (en) 2018-05-17
DK3538132T3 (da) 2021-04-06
EP3538132B1 (en) 2020-12-30
EP3538132A1 (en) 2019-09-18

Similar Documents

Publication Publication Date Title
IL279020B1 (en) Use of chloroquine and calamizole compounds to treat inflammatory and cancerous conditions
ZA201807084B (en) Methods of treatment of cholestatic diseases
PT3169328T (pt) Derivados de quinolina para o tratamento de doenças inflamatórias
IL257561A (en) Methods for treating inflammatory diseases
HUS2500033I1 (hu) Intrahepatikus kolesztázisos betegségek kezelése
IL253118A0 (en) Methods for treating inflammatory diseases
PT3865484T (pt) Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas
PL3492632T4 (pl) Sposoby traktowania materiałów zawierających lit
PT3097085T (pt) Derivados de benzoxazinona para tratamento de doenças de pele
IL246721B (en) History of 5-benzylisoquinoline for the treatment of cardiovascular diseases
IL253847A0 (en) Methods of treating diseases
GB201412578D0 (en) Treatment of neurological diseases
PT3538132T (pt) Insulina retal para tratamento de doenças inflamatórias intestinais
PL3377075T3 (pl) Kompozycja do leczenia nieswoistego zapalenia jelit
GB201515244D0 (en) Treatment of inflammatory disease or condition
HUE042691T2 (hu) Tiazolo-pirimidinon felhasználása gyulladásos bélbetegségek kezeléséhez
HUP1500192A2 (hu) Mannooligoszaharidok alkalmazása humán gyulladásos bélbetegségek kezelésénél
GB201517565D0 (en) Treatment of genetic diseases
GB201414023D0 (en) Treatment of autoimmune diseases
GB201514909D0 (en) Treatment of autoimmune diseases
TH1501006822A (th) การใช้ไทอะโซโล ไพริมิดิโนนสำหรับการรักษาโรคลำไส้อักเสบ
GB201604253D0 (en) Treatment of genetic diseases
AU2015902358A0 (en) Treatment of inflammatory disease